Mitochondrial dysfunction in skeletal muscle of amyloid precursor protein-overexpressing mice

Journal of Biological Chemistry

Volumn 287, Issue 24, 2012, Pages 20534-20544

  Boncompagni, Simona ^a   Moussa, Charbel E H ^b   Levy, Ezra ^d   Pezone, Matthew J ^d   Lopez, José R ^c   Protasi, Feliciano ^a   Shtifman, Alexander ^d  

^a UNIVERSITY OF CHIETI   (Italy)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEINS; ANAEROBIC GLUCOSE; CELLULAR ORGANELLES; CLINICAL FEATURES; GLUTATHIONES; INCLUSION BODY MYOSITIS; INTRACELLULAR ACCUMULATION; MEMBRANE POTENTIALS; MICROSCOPIC ANALYSIS; MITOCHONDRIAL DYSFUNCTION; MUSCLE CELL; MUSCLE FIBER; MYOFIBERS; PLASMALEMMA; PROTEOLYTIC FRAGMENTS; REDOX STATE; SKELETAL MUSCLE; SUBSTANTIAL REDUCTION; TCA CYCLE; TRANSGENIC MICE;

CELL MEMBRANES; MAMMALS; MITOCHONDRIA; MUSCLE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

GLYCOPROTEINS;

AMYLOID PRECURSOR PROTEIN; GLUTATHIONE; REACTIVE OXYGEN METABOLITE;

ANAEROBIC GLYCOLYSIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CALCIUM TRANSPORT; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE POTENTIAL; CELL PH; CITRIC ACID CYCLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; INCLUSION BODY MYOSITIS; MITOCHONDRION; MOUSE; MUSCLE CELL; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CALCIUM; CELL MEMBRANE; CITRIC ACID CYCLE; CYTOPLASM; GLUCOSE; HUMANS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, TRANSGENIC; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; MYOSITIS, INCLUSION BODY; OXIDATION-REDUCTION;

MUS; MUS MUSCULUS;

EID: 84862004159     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.359588     Document Type: Article

References (49)

1. Askanas, V., Serratrice, G., and Engel, W. K. (1998) Inclusion-Body Myositis and Myopathies, Cambridge University Press, Cambridge
2. Askanas, V., Alvarez, R. B., and Engel, W. K. (1993) β-Amyloid precursor epitopes in muscle fibers of inclusion body myositis. Ann. Neurol. 34, 551-560 (Pubitemid 23289406)
3. Askanas, V., Serdaroglu, P., Engel, W. K., and Alvarez, R. B. (1991) Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion body myositis and oculopharyngeal muscular dystrophy. Neurosci. Lett. 130, 73-76
4. Askanas, V., Engel, W. K., Bilak, M., Alvarez, R. B., and Selkoe, D. J. (1994) Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau. Am. J. Pathol. 144, 177-187 (Pubitemid 24158371)
5. Fidziańska, A., and Glinka, Z. (2006) Rimmed vacuoles with β-amyloid and Tau protein deposits in the muscle of children with hereditary myopathy. Acta Neuropathol. 112, 185-193
6. Schmidt, J., Barthel, K., Wrede, A., Salajegheh, M., Bähr, M., and Dalakas, M. C. (2008) Interrelation of inflammation and APP in sIBM. IL-1β induces accumulation of β-amyloid in skeletal muscle. Brain 131, 1228-1240
7. Vattemi, G., Nogalska, A., King Engel, W., D'Agostino, C., Checler, F., and Askanas, V. (2009) Amyloid-β42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis. Acta Neuropathol. 117, 569-574
8. Nogalska, A., D'Agostino, C., Engel, W. K., Klein, W. L., and Askanas, V. (2010) Novel demonstration of amyloid-β oligomers in sporadic inclusion- body myositis muscle fibers. Acta Neuropathol. 120, 661-666
9. Askanas, V., Engel, W. K., and Alvarez, R. B. (1992) Light and electron microscopic localization of β-amyloid protein in muscle biopsies of patients with inclusion-body myositis. Am. J. Pathol. 141, 31-36
10. Askanas, V., McFerrin, J., Alvarez, R. B., Baqué, S., and Engel, W. K. (1997) βAPP gene transfer into cultured human muscle induces inclusion-body myositis aspects. Neuroreport 8, 2155-2158 (Pubitemid 27319663)
11. Askanas, V., McFerrin, J., Baqué, S., Alvarez, R. B., Sarkozi, E., and Engel, W. K. (1996) Transfer of β-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. Proc. Natl. Acad. Sci. U.S.A. 93, 1314-1319
12. Oldfors, A., Moslemi, A. R., Jonasson, L., Ohlsson, M., Kollberg, G., and Lindberg, C. (2006) Mitochondrial abnormalities in inclusion-body myositis. Neurology 66, S49-55 (Pubitemid 43739984)
13. Horvath, R., Fu, K., Johns, T., Genge, A., Karpati, G., and Shoubridge, E. A. (1998) Characterization of the mitochondrial DNA abnormalities in the skeletal muscle of patients with inclusion body myositis. J. Neuropathol. Exp. Neurol. 57, 396-403 (Pubitemid 28237323)
14. Sugarman, M. C., Kitazawa, M., Baker, M., Caiozzo, V. J., Querfurth, H. W., and LaFerla, F. M. (2006) Pathogenic accumulation of APP in fast twitch muscle of IBM patients and a transgenic model. Neurobiol. Aging 27, 423-432 (Pubitemid 43185327)
15. Sugarman, M. C., Yamasaki, T. R., Oddo, S., Echegoyen, J. C., Murphy, M. P., Golde, T. E., Jannatipour, M., Leissring, M. A., and LaFerla, F. M. (2002) Inclusion body myositis-like phenotype induced by transgenic overexpression of βAPP in skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 99, 6334-6339 (Pubitemid 34493312)
16. Moussa, C. E., Fu, Q., Kumar, P., Shtifman, A., Lopez, J. R., Allen, P. D., LaFerla, F., Weinberg, D., Magrane, J., Aprahamian, T., Walsh, K., Rosen, K. M., and Querfurth, H. W. (2006) Transgenic expression of β-APP in fast-twitch skeletal muscle leads to calcium dyshomeostasis and IBM-like pathology. FASEB J. 20, 2165-2167
17. 2+ dysregulation in skeletal muscle. Muscle Nerve 42, 731-738
18. Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M. W., and Sheu, S. S. (2004) Calcium, ATP, and ROS.Amitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol. 287, C817-C833 (Pubitemid 39238305)
19. 2+transport by mitochondria. Nature 315, 635
20. Denton, R. M., and McCormack, J. G. (1986) The calcium sensitive dehydrogenases of vertebrate mitochondria. Cell Calcium 7, 377-386 (Pubitemid 17215944)
21. Wang, W., Fang, H., Groom, L., Cheng, A., Zhang, W., Liu, J., Wang, X., Li, K., Han, P., Zheng, M., Yin, J., Wang, W., Mattson, M. P., Kao, J. P., Lakatta, E. G., Sheu, S. S., Ouyang, K., Chen, J., Dirksen, R. T., and Cheng, H. (2008) Superoxide flashes in single mitochondria. Cell 134, 279-290 (Pubitemid 352010332)
22. Chen, Q., Chai, Y. C., Mazumder, S., Jiang, C., Macklis, R. M., Chisolm, G. M., and Almasan, A. (2003) The late increase in intracellular free radical oxygen species during apoptosis is associated with cytochrome c release, caspase activation, and mitochondrial dysfunction. Cell Death Differ 10, 323-334 (Pubitemid 36582370)
23. Casley, C. S., Canevari, L., Land, J. M., Clark, J. B., and Sharpe, M. A. (2002) β-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J. Neurochem. 80, 91-100 (Pubitemid 34614581)
24. Casley, C. S., Land, J. M., Sharpe, M. A., Clark, J. B., Duchen, M. R., and Canevari, L. (2002)β-Amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol. Dis. 10, 258-267 (Pubitemid 35217579)
25. Eckert, A., Hauptmann, S., Scherping, I., Rhein, V., Müller-Spahn, F., Götz, J., and Müller, W. E. (2008) Soluble β-amyloid leads to mitochondrial defects in amyloid precursor protein and Tau transgenic mice. Neurodegener Dis. 5, 157-159 (Pubitemid 351347837)
26. Grant, S. M., Shankar, S. L., Chalmers-Redman, R. M., Tatton, W. G., Szyf, M., and Cuello, A. C. (1999) Mitochondrial abnormalities in neuroectodermal cells stably expressing human amyloid precursor protein (hAPP751). Neuroreport 10, 41-46 (Pubitemid 29090475)
27. Keil, U., Bonert, A., Marques, C. A., Scherping, I., Weyermann, J., Strosznajder, J. B., Müller-Spahn, F., Haass, C., Czech, C., Pradier, L., Müller, W. E., and Eckert, A. (2004) Amyloid β-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J. Biol. Chem. 279, 50310-50320 (Pubitemid 39577847)
28. Pereira, C., Santos, M. S., and Oliveira, C. (1998) Mitochondrial function impairment induced by amyloid β-peptide on PC12 cells. Neuroreport 9, 1749-1755 (Pubitemid 28289179)
29. 2+ release and contractility in skeletal muscle. Neurobiol. Aging 31, 2080-2090
30. Boncompagni, S., Rossi, A. E., Micaroni, M., Beznoussenko, G. V., Polishchuk, R. S., Dirksen, R. T., and Protasi, F. (2009) Mitochondria are linked to calcium stores in striated muscle by developmentally regulated tethering structures. Mol. Biol. Cell 20, 1058-1067
31. Chung, M. J., and Suh, Y. L. (2002) Ultrastructural changes of mitochondria in the skeletal muscle of patients with amyotrophic lateral sclerosis. Ultrastruct. Pathol. 26, 3-7
32. Dobrowolny, G., Aucello, M., Rizzuto, E., Beccafico, S., Mammucari, C., Bonconpagni, S., Belia, S., Wannenes, F., Nicoletti, C., Del Prete, Z., Rosenthal, N., Molinaro, M., Protasi, F., Fanò, G., Sandri, M., and Musarò, A. (2008) Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab. 8, 425-436
33. Yunis, E. J., and Samaha, F. J. (1971) Inclusion body myositis. Lab. Invest. 25, 240-248
34. 2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes. J. Biol. Chem. 273, 10223-10231
35. Aleardi, A. M., Benard, G., Augereau, O., Malgat, M., Talbot, J. C., Mazat, J. P., Letellier, T., Dachary-Prigent, J., Solaini, G. C., and Rossignol, R. (2005) Gradual alteration of mitochondrial structure and function by β-amyloids. Importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release. J. Bioenerg. Biomembr. 37, 207-225 (Pubitemid 41420458)
36. Khalifat, N., Puff, N., Dliaa, M., and Angelova, M. I. (2012) Amyloid-β and the failure to form mitochondrial cristae: a biomimetic study involving artificial membranes. J. Alzheimers Dis. 28, 33-48
37. Hong, W. K., Han, E. H., Kim, D. G., Ahn, J. Y., Park, J. S., and Han, B. G. (2007) Amyloid-β-peptide reduces the expression level of mitochondrial cytochrome oxidase subunits. Neurochem. Res. 32, 1483-1488 (Pubitemid 47094410)
38. Rosen, K. M., Veereshwarayya, V., Moussa, C. E., Fu, Q., Goldberg, M. S., Schlossmacher, M. G., Shen, J., and Querfurth, H. W. (2006) Parkin protects against mitochondrial toxins and β-amyloid accumulation in skeletal muscle cells. J. Biol. Chem. 281, 12809-12816 (Pubitemid 43855373)
39. Askanas, V., Engel, W. K., and Nogalska, A. (2009) Inclusion body myositis. A degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation. Brain Pathol. 19, 493-506
40. Nogalska, A., D'Agostino, C., Terracciano, C., Engel, W. K., and Askanas, V. (2010) Impaired autophagy in sporadic inclusion-body myositis and in endoplasmic reticulum stress-provoked cultured human muscle fibers. Am. J. Pathol. 177, 1377-1387
41. Boncompagni, S., Rossi, A. E., Micaroni, M., Hamilton, S. L., Dirksen, R. T., Franzini-Armstrong, C., and Protasi, F. (2009) Characterization and temporal development of cores in a mouse model of malignant hyperthermia. Proc. Natl. Acad. Sci. U.S.A. 106, 21996-22001
42. Zissimopoulos, S., Docrat, N., and Lai, F. A. (2007) Redox sensitivity of the ryanodine receptor interaction with FK506-binding protein. J. Biol. Chem. 282, 6976-6983 (Pubitemid 47093660)
43. Zissimopoulos, S., and Lai, F. A. (2006) Redox regulation of the ryanodine receptor/calcium release channel. Biochem. Soc. Trans. 34, 919-921 (Pubitemid 44796450)
44. Allen, D. G., Lännergren, J., and Westerblad, H. (1995) Muscle cell function during prolonged activity. Cellular mechanisms of fatigue. Exp. Physiol. 80, 497-527
45. 2+-ATPase isoforms. Diverse responses to acidosis. Biochem. J. 321, 545-550
46. 2+ channels in central neurones. Neurobiol. Aging 27, 439-445
47. Scragg, J. L., Fearon, I. M., Boyle, J. P., Ball, S. G., Varadi, G., and Peers, C. (2005) Alzheimer's amyloid peptides mediate hypoxic up-regulation of L-type Ca2+ channels. FASEB J. 19, 150-152 (Pubitemid 40069948)
48. 2+ channels. Mol. Cells 32, 289-294
49. 2+ in adult Alzheimer's disease mice. J. Neurochem. 105, 262-271